Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue

Neoplasma

Volumn 61, Issue 5, 2014, Pages 533-539

  Jia, M Y ^a   Wang, Y J ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Colorectal carcinoma; FUBP1; Immunohistochemistry; qPCR; Western blot

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; FAR UPSTREAM ELEMENT BINDING PROTEIN 1; MESSENGER RNA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; DNA HELICASE; FUBP1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE AMPLIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PATHOGENESIS; PATHOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR BIOPSY; WESTERN BLOTTING; AGED; CHEMISTRY; COLORECTAL TUMOR; GENETICS;

ADULT; AGED; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; DNA HELICASES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84907294742     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_065     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E et al. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69–90. http://dx.doi.org/10.3322/caac.20107
2. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B et al. Colorectal cancer. Lancet. 2010; 375: 1030–1047. http://dx.doi.org/10.1016/S0140-6736(10)60353-4
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61: 759–67. http://dx.doi.org/10.1016/0092-8674(90)90186-I
4. Li XD, Miao SY, Wang GL, Yang L, Shu YQ et al. Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics. Onkologie. 2010; 33(7): 353–8. http://dx.doi.org/10.1159/000315380
5. Wang F, Zhang P, Ma Y, Yang J, Moyer MP et al. NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA. Cancer Lett. 2012; 314: 223–31. http://dx.doi.org/10.1016/j.canlet.2011.09.033
6. Xi RC, Biao WS, Gang ZZ. Significant elevation of survivin and livin expression in human colorectal cancer: inverse correlation between expression and overall survival. Onkologie. 2011; 34(8-9): 428–32. http://dx.doi.org/10.1159/000331132
7. Zheng Y, Miskimins WK. Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int J Biochem Cell Biol. 2011; 43: 1641–8. http://dx.doi.org/10.1016/j.biocel.2011.08.001
8. Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science. 2011; 333: 1453–5. http://dx.doi.org/10.1126/science.1210557
9. Engidawork E, Afjehi-Sadat L, Yang JW, Slavc I, Lubec G. Protein chemical identification and characterization of the human variants of far upstream element binding protein in medulloblastoma DAOY cell line. Int J Oncol. 2006; 29: 721–36.
10. Gagne JP, Gagne P, Hunter JM, Bonicalzi ME, Lemay JF et al. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D. Mol Cell Biochem. 2005; 275: 25–55. http://dx.doi.org/10.1007/s11010-005-7556-1
11. Sanz R, Aragues R, Stresing V, Martin B, Landemaine T et al. Functional pathways shared by liver and lung metastases: a mitochondrial chaperone machine is up-regulated in soft-tissue breast cancer metastasis. Clin Exp Metastasis. 2007; 24: 673–83. http://dx.doi.org/10.1007/s10585-007-9124-4
12. Singer S, Malz M, Herpel E, Warth A, Bissinger M et al. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res. 2009; 69: 2234–43. http://dx.doi.org/10.1158/0008-5472.CAN-08-3338
13. Weber A, Kristiansen I, Johannsen M, Oelrich B, Scholmann K et al. The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC cancer. 2008; 8: 369. http://dx.doi.org/10.1186/1471-2407-8-369
14. Brauckhoff A, Malz M, Tschaharganeh D, Malek N, Weber A et al. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells. J Hepatol. 2011; 55: 1049–57. http://dx.doi.org/10.1016/j.jhep.2011.02.019
15. Vindigni A, Ochem A, Triolo G, Falaschi A. Identification of human DNA helicase V with the far upstream element-binding protein. Nucleic Acids Res. 2001; 29: 1061–7. http://dx.doi.org/10.1093/nar/29.5.1061
16. Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D et al. Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol. 1996; 16: 2656–69.
17. Chen M, Zhang J, Li N, Qian Z, Zhu M et al. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One. 2011; 6: e25564. http://dx.doi.org/10.1371/journal.pone.0025564
18. Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu ML, Joos S, Devens F et al. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology. 2009; 50: 1121–9. http://dx.doi.org/10.1002/hep.23098
19. Sanderson LM, Boekschoten MV, Desvergne B, Muller M, Kersten S. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver. Physiol Genomics. 2010; 41: 42–52. http://dx.doi.org/10.1152/physiolgenomics.00127.2009
20. Lu HN, Zhang FC, Wang YJ. The effect of far upstream element binding protein-1 on the pathogenesis of human hepatocellular carcinomas. Chinese journal of hepatology. 2011; 19: 696–8.
21. Tacke MD, Berndt PC, Hagmann M-LD, Karl JD, Langen HD et al., inventors; Use of the Far Upstream Element (FUSE) Binding Protein (FUBP) as a Marker for Colorectal Cancer 2005.
22. Kuramitsu Y, Taba K, Ryozawa S, Yoshida K, Zhang X et al. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Anticancer Res. 2010; 30: 3367–72.
23. Kim MJ, Park BJ, Kang YS, Kim HJ, Park JH et al. Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation. Nat Genet. 2003; 34: 330–6. http://dx.doi.org/10.1038/ng1182
24. Huth JR, Yu L, Collins I, Mack J, Mendoza R et al. NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. J Med Chem. 2004; 47: 4851–7. http://dx.doi.org/10.1021/jm0497803
25. Jang M, Park BC, Kang S, Chi SW, Cho S et al. Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene. Oncogene. 2009; 28: 1529–36. http://dx.doi.org/10.1038/onc.2009.11